{"entity":{"type":"insider","cik":"0001744959","url":"/insider/0001744959","json_url":"/insider/0001744959.json","name":"DEMAREE JOHN","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":2,"n_filings":2,"first":"2018-12-11","last":"2020-08-27","span_basis":"filed_date"},"name_variants":[{"name":"DEMAREE JOHN","source":"filing","n_filings":2,"first_seen":"2018-12-11","last_seen":"2020-08-27"}],"transactions":[{"id":2902048,"accession":"0001209191-20-048515","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-048515","line_url":"/filing/0001209191-20-048515#line-1","is_derivative":false,"issuer_cik":"0001503802","issuer_name":"Karyopharm Therapeutics Inc.","issuer_ticker":"KPTI","issuer_name_source":null,"issuer_url":"/issuer/0001503802","owner_cik":"0001744959","owner_name":"DEMAREE JOHN","owner_display_name":"DEMAREE JOHN","owner_url":"/insider/0001744959","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7500.0,"shares_display":"7,500","price_per_share":14.535,"price_display":"14.54","price_state":"stated","total_value":109012.5,"total_display":"109,012.50","total_whole":"109,013","shares_owned_after":7500.0,"shares_owned_after_display":"7,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-26","filed_date":"2020-08-27","scope":"insider"},{"id":6354528,"accession":"0001562180-18-004904","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001562180-18-004904","line_url":"/filing/0001562180-18-004904#line-1","is_derivative":false,"issuer_cik":"0001560241","issuer_name":"G1 Therapeutics, Inc.","issuer_ticker":"GTHX","issuer_name_source":null,"issuer_url":"/issuer/0001560241","owner_cik":"0001744959","owner_name":"DEMAREE JOHN","owner_display_name":"DEMAREE JOHN","owner_url":"/insider/0001744959","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":33.1511,"price_display":"33.15","price_state":"stated","total_value":33151.1,"total_display":"33,151.10","total_whole":"33,151","shares_owned_after":5250.0,"shares_owned_after_display":"5,250","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-10","filed_date":"2018-12-11","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":2,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":2},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001503802","name":"Karyopharm Therapeutics Inc.","url":"/issuer/0001503802","role":"Officer (Chief Commercial Officer)","n_filings":1,"first_seen":"2020-08-27","last_seen":"2020-08-27"},{"type":"issuer","type_label":"ISSUER","cik":"0001560241","name":"G1 Therapeutics, Inc.","url":"/issuer/0001560241","role":"Officer (Chief Commercial Officer)","n_filings":1,"first_seen":"2018-12-11","last_seen":"2018-12-11"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001744959","retrieved_at":"2026-08-22T10:22:10+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}